Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2006; 131(46): 2601-2604
DOI: 10.1055/s-2006-956256
DOI: 10.1055/s-2006-956256
Aktuelle Diagnostik & Therapie | Review article
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York
Monogenetische Hypertonie
Monogenic hypertensionFurther Information
Publication History
eingereicht: 7.10.2006
akzeptiert: 26.10.2006
Publication Date:
09 November 2006 (online)
Schlüsselwörter
monogenetische Hypertonie - Liddle-Syndrom - Gordon-Syndrom - Hyperaldosteronismus - Mineralokortikoidexzess
Key words
monogenic hypertension - Liddle syndrome - Gordon syndrome - hyperaldosteronism - mineralocorticoid excess
Literatur
- 1 Ferrari P, Lovati E, Frey F J. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens. 2000; 18 241-248
- 2 Geller D S, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai F T, Sigler P B, Lifton R P. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000; 289 119-123
- 3 Hansson J H, Schild L, Lu Y, Wilson T A, Gautschi I, Shimkets R, Nelson-Williams C, Rossier B C, Lifton R P. A De novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A. 1995; 92 11495-11499
- 4 Kahle K T, Wilson F H, Leng Q, Lalioti M D, O’Connell A D, Dong K, Rapson A K, MacGregor G G, Giebisch G, Hebert S C, Lifton R P. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet. 2003; 35 372-376
- 5 Lalioti M D, Zhang J, Volkman H M, Kahle K T, Hoffmann K E, Toka H R, Nelson-Williams C, Ellison D H, Flavell R, Booth C J, Lu Y, Geller D S, Lifton R P. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006; 38 1124-1132
- 6 Lifton R P, Gharavi A G, Geller D S. Molecular mechanisms of human hypertension. Cell. 2001; 104 545-556
- 7 Lifton R P, Dluhy R G, Powers M, Rich G M, Cook S, Ulick S, Lalouel J M. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992; 355 262-265
- 8 Luft F C. Monogenic hypertension: lessons from the genome. Kidney Int. 2001; 60 381-390
- 9 Mune T, Rogerson F M, Nikkila H, Agarwal A K, White P C. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet. 1995; 10 394-399
- 10 Rafestin-Oblin M E, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology. 2003; 144 528-533
- 11 Toka H R, Luft F C. Monogenic forms of human hypertension. Semin Nephrol. 2002; 22 81-88
- 12 Wilson F H, Disse-Nicodeme S, Choate K A, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford D V, Lipkin G W, Achard J M, Feely M P, Dussol B, Berland Y, Unwin R J, Mayan H, Simon D B, Farfel Z, Jeunemaitre X, Lifton R P. Human hypertension caused by mutations in WNK kinases. Science. 2001; 293 1107-1112
Prof. Dr. J. Hoyer
Klinik für Innere Medizin und Nephrologie Universitätsklinikum Gießen und Marburg GmbH Standort Marburg
Baldingerstraße
35033 Marburg
Phone: 06421 2866480
Fax: 06421 2866365
Email: hoyer@med.uni-marburg.de